Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 85456

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : March | Volume : 16 | Issue : 3 | Page : BC01 - BC06 Full Version

Biophysical Characterisation of Amadori Modified Human Serum Albumin: A Prognostic Biomarker for Diabetic Complications


Published: March 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/51899.16109
Binish Arif, Zubair Ahmad, Gulzar Ahmad Bhat, Syed Mudassar, Khursheed Aalam

1. Senior Resident, Department of Clinical Biochemistry, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India. 2. Consultant, Department of Radiodiagnosis, Government Medical College, Srinagar, Jammu and Kashmir, India. 3. Senior Resident, Department of Clinical Biochemistry, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India. 4. Professor and Head, Department of Clinical Biochemistry, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India. 5. Professor, Department of Biochemistry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

Correspondence Address :
Dr. Binish Arif,
Senior Resident, Department of Clinical Biochemistry, Sher-i-Kashmir Institute of
Medical Sciences, Srinagar-190011, Jammu and Kashmir, India.
E-mail: drbinish11@gmail.com

Abstract

Introduction: Glycation of biological macromolecules particularly protein leads to the generation of early and Advanced Glycation End (AGE) products. The interest in early glycation of protein is driven due to the fact of Amadori modified proteins having role in diabetic complications.

Aim: To analyse the biophysical characterisation of Amadori modified human serum albumin as a prognostic biomarker for diabetic complications.

Materials and Methods: This in-vitro experimental study was conducted at Department of Biochemistry, J.N. Medical College, Aligarh Muslim University, Uttar Pradesh, India, from May 2010 to December 2012. The structural characterisation of EGPs was generated by incubating Human Serum Albumin (HSA) with glucose for about a week. The generation of Early Glycation Products (EGPs) of HSA was quantitated as Hydroxy Methyl Furfural (HMF) by ThioBarbituric Acid (TBA) assay and authenticated by boronate affinity chromatography. Moreover, High Performance Liquid Chromatography (HPLC) and Electro Spray Ionisation/Mass Spectrometry (ESI/MS) was carried out to validate the presence of Amadori product formed. Additionally, Circular Dichroism (CD) and thermal denaturation studies were used to investigate the structural changes in Amadori albumin.

Results: Glycated HSA was obtained as detected by the presence of HMF and chromatography peaks. On stratification, the structural perturbation was observed in Amadori HSA. Furthermore, the generation of furosine was also confirmed by obtaining a new peak in the HPLC profile of glycated HSA. The ESI/MS result also substantiated the presence of Amadori products.

Conclusion: The therapeutic strategies that negate the Amadori modification of albumin might be a logical approach in the prevention of diabetic complications.

Keywords

Advanced glycation end product, Amadori adduct, Diabetes, Glycation, Hydroxy methyl furfural

Glycation causes the carbonyl group in acyclic glucose to react with a free amino group in the protein to generate a Schiff base or aldimine intermediate, which then undergoes an Amadori rearrangement to form a stable ketoamine that can cyclise to a ring structure (1). Schiff’s base and fructosamines are called as early glycation adducts or Amadori product (2). This product is subsequently subjected to a series of condensations with additional amines, dehydrations, and oxidative fragmentation cycles, resulting in a family of heterogeneous chemical substances known as Advanced Glycation End products (AGEs) (3).

In diabetes, excess glucose binds to proteins all over the body, changing their form and properties in ways that have been shown to harm human organ structure and function (4),(5),(6). Moreover, the early and advanced glycation products formed play a prominent role in the development of diabetic complications. It has been shown that both Amadori product as well as Amadori-derived AGEs are involved in the secondary complications of diabetes (7).

In the recent years, the role of AGEs and the structural protein damage induced by it has been extensively researched. However, a little focus has been gained by the EGPs. Amadori adducts have been found to play a key role among the chemicals involved in tissue injury (8),(9),(10),(11),(12). The absorption of LDL in blood arteries may be increased, resulting in atherogenesis (13). Free radical mediated damage is also increased (14). These biochemical abnormal changes probably play a role in the pathogenesis of the early functional changes in the diabetic microvasculature.

Albumin is the most abundant protein in circulation, prone to glycation (15). Glycation induced structural alterations has profound impact on the functional properties of albumin (16). Evidence suggests that ε-amino groups of lysine residue in HSA are preferred locus for early glycation (17),(18). In patients with type 1 diabetes, elevated levels of Amadori glycated albumin are associated with diabetic nephropathy and retinopathy independently, while it is favourably associated with cardiovascular disease in patients with type 2 diabetes (19),(20), pointing towards the fact that this analyte may serve as a biomarker for diabetic complications.

In the present study, Human Serum Albumin (HSA) was incubated with different concentrations of glucose to produce Amadori-rich glycated HSA for about one week. Hydroxy Methyl Furfural (HMF) tested the presence of Amadori product, and boronate affinity chromatography was also used. Furthermore, to authenticate the presence of Amadori-HSA, High Performance Liquid Chromatography (HPLC) was done using furosine as standard. The Amadori-HSA formed was further substantiated by Electro Spray Ionisation/Mass Spectrometry (ESI/MS). Moreover, the structural changes were investigated by CD and thermal denaturation studies. Hence, the present study was conducted to analyse the biophysical characterisation of Amadori modified human serum albumin as a prognostic biomarker for diabetic complications.

Material and Methods

This in-vitro experimental study was conducted at Department of Biochemistry, J.N. Medical College, Aligarh Muslim University, Uttar Pradesh, India, from May 2010 to December 2012. Human serum albumin, and m-aminophenylboronic acid, were purchased from Sigma Chemical company (St. Louis, USA). Furosine was obtained from Polypeptide Laboratories (Strasbourg, France). D-glucose and sodium borohydride (NaBH4) were obtained from Merck (Darmstadt, Germany). Nitroblue Tetrazolium (NBT) was purchased from SRL Chemicals (India). All other chemicals and reagents used were of highest analytical grade available.

Formation of 5-Hydroxymethylfurfural (HMF): The Thiobarbituric Acid (TBA) reaction was used to detect the formation of 5- HMF from the Amadori product of glycated HSA, as described by Ney KAT et al., (21). A 1 mL of native HSA and modified-HSA samples were mixed with 1 mL of oxalic acid (1 M) and incubated for 2 hours at 100°C. The protein from the assay mixture was then extracted using 40% trichloroacetic acid precipitation. TBA (0.05 M) was added to 0.75 mL of protein free filtrate and incubated for 40 minutes at 40°C. The colour was measured at 443 nm, and the amount of HMF was determined using a molar extinction coefficient of 4×104/cm/mol.

Affinity chromatography: The production of Amadori adducts in the glycated-HSA samples was further investigated using Chesne S et al., method of boronate affinity chromatography (22). Using binding buffer, 10 mL of the separating gel (11 mmol m-aminophenylboronic acid) was equilibrated (0.2 M ammonium acetate, pH 8.8). Binding buffer was used to dilute native and glycated-HSA samples, and 1 mL of the solution was administered per mL of the separating gel. The absorbance of each fraction was measured at 280 nm after 3 mL fractions were collected. The boronate bound albumin (corresponding to the Amadori product) was eluted using the elution buffer after non bound albumin was collected (NaCl 0.15 M, MgCl2 10 mM, sorbitol 0.2 M, pH 3.4).

Circular Dichroism (CD): A spectropolarimeter was used to investigate glycation-induced conformational/structural changes (23). By placing samples in a temperature-controlled cell holder attached to Neslab’s RTE 110 water bath (temperature precision of 0.1°C), CD profiles were obtained at 25°C. A 3.0 μM was chosen as the protein concentration. The Mean Residue Ellipticity (MRE) was computed using the formula below, and the result was represented in deg cm2 mol-1.

MRE = CD/ (10 × n × l × Cp)

The MRE was calculated according to the formula given above and the result was expressed: in deg cm2 mol-1

Where, CD is the cell path length in centimetres, ‘n’ is the number of amino acid residues in human albumin (585), ‘l’ is the cell path length in centimetres, and ‘Cp’ is the mole fraction. K2D programme computed the percentage of helix, sheet, and random coil.

Thermal denaturation studies: To investigate the stability of HSA after glucose modification, native and glycated-HSA samples were heated under controlled conditions. The samples’ midpoint melting temperature (Tm) was determined (24). The samples were melted at a rate of 1.0°C/min from 30°C - 90°C. With rising temperature, the change in absorbance at 280 nm was measured.

The following equation was used to compute percent denaturation:

Percent denaturation = ATA30 / AmaxA30 × 100

where,

AT=Absorbance at temperature T°C

Amax=Final absorbance on the completion of denaturation (95°C)

A30=Initial absorbance at 30°C

HPLC detection of furosine: By using a capillary HPLC system (Aligent 1100 series) and a synergi C18 analytical column, furosine (a compound generated by acid hydrolysis of fructosyl lysine) was detected in glycated-HSA. The native and glycated-HSA samples were hydrolysed in 6 N HCl at 95°C for 18 hours prior to loading (25). A medium-grade filter paper was used to filter the hydrolysates. The following was the general chromatographic setup: The eluents employed were 0.4% acetic acid (Solvent A), 0.2% acetonitrile (Solvent B), each containing 2% formic acid, on a C-18 reverse phase column (4x250 mm with 5 m particle size). The gradient elution strategy was as follows: 0-2% solvent B in the first 5 minutes, 2-6% solvent B in 19 minutes, 6-80% solvent B in 11 minutes, and then 80% to wash the leftover material off the column at a constant flow rate of 0.5 mL/min.

Electrospray Ionisation Mass Spectrometry (ESI-MS): ESI-MS is a potent technique for isolating intact ions from big, complicated species in solution in vacuum (26). Authors employed an orthogonal Time Of Flight (TOF) mass spectrometer with a standard ESI source (Applied Biosystems Mariner Atmospheric Pressure Ionisation TOF Workstation, Framingham, MA, USA) for this experiment. The nebuliser gas utilised was nitrogen. For direct infusion of the sample onto the mass spectrometer, the instrument was equipped with an integrated syringe pump with a twin syringe rack. The spray tip potential was set at 4,000 V and the sciex heater was set to 350°C. The mass spectrometer was set to positive ion mode and mass spectra were taken over a mass range of 100-800 m/z.

Statistical Analysis

The data are presented as mean±SD. Statistical significance of the data was determined by student’s t-test (stat graphics, origin 6.1). A p-value ≤0.05 was considered statistically significant.

Results

In the previous work, authors have reported that, HSA incubated with increasing concentration of glucose had different content of the Amadori-albumin. Highest amount of the amadori albumin was found in the HSA sample incubated with 50 mM glucose as determined by NBT assay (27). Native and Amadori-albumin were characterised by various biophysical techniques. Glycation induced structural changes in HSA were evaluated by UV and fluorescence. Native albumin gave a characteristic peak at 280 nm whereas Amadori-albumin showed hyperchromicity (58.4%). Fluorescence Intensity (FI) was found to be significantly decreased in Amadori-albumin as compared to native albumin. Amadori-albumin showed 43.2% reduction in the FI.

Thiobarbituric acid assay for Hydroxymethyl Furfural (HMF): Thiobarbituric acid assay, which evaluates the quantity of ketoamine attached to protein, confirmed the production of Amadori-albumin (21). HSA modified with 12.5 mM, 25 mM, and 50 mM glucose, yielded HMF 2.8, 4.7, and 8.9 nmol/mg, respectively (Table/Fig 1). Under similar conditions HSA incubated without glucose, had almost non existent content of HMF. Furthermore, reduction with Sodium borohydride (NaBH4) resulted in a considerable decrease in HMF concentration, which was determined to be 1.4, 2.2, and 3.1 nmol/mg, respectively (Table/Fig 1).

Boronate affinity chromatography: To authenticate Amadori formation, native and glycated-HSA samples were run through a boronate column. In case of native HSA, no significant binding was found. Through fractionation, the amount of native HSA loaded emerged in wash (W). Glycated-HSA samples, on the other hand, revealed a progressive decrease in the unbound fraction and a systemic increase in the boronate retained fraction (Table/Fig 2)a-d. Amadori formation was clearly visible on Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) of the wash through and eluted fraction (E). Amadori HSA was further characterised using HSA treated with 50 mM glucose.

Circular Dichroism (CD) analysis of native and glycated-HSA: Circular dichroism was used to assess early glycation-induced secondary alterations in HSA. In the far-UV range, the amide chromophores of the proteins’ peptide bonds show ellipticity (200-250 nm). Negative bands between 222 nm and 208 nm are produced by proteins with high alpha-helix content. Proteins with pure beta-sheets, on the other hand, show negative bands between 216 nm and 175 nm. The far-UV CD profile of native HSA and its 50 mM glucose modified equivalent is shown in (Table/Fig 3). The native and glycated-HSA samples have essentially identical far UV CD profiles. However, both native and glycated-HSA samples, on the other hand, showed two minima, one at 208 nm and the other at 222 nm, indicating the presence of α-helical content. Native HSA had a 58%-helix, while glycated-HSA had a 65%-helix. HSA’s increased
alpha-helical content after glycation shows conformational changes. (Table/Fig 4) summarises the MRE and other parameters.

Near-UV CD measurements of native and glycated-HSA: CD measurements in the near-UV region were used to investigate glucose-induced structural alterations in more depth. It should be remembered that peptide backbone orientations influence far-UV CD characteristics, whereas side chains of aromatic amino acids (phenylalanine, tyrosine, and tryptophan) influence CD characteristics in the near-UV CD region (250-300 nm) (28),(29), revealing the proteins’ tertiary structure. The near-UV CD profile of native and glycated-HSA is shown in (Table/Fig 5). Two minima were observed in native HSA, one at 262 nm and the other at 268 nm. The 292 nm minimum is typical of disulphide and aromatic chromophores (30). The reduction of signal at 292 nm, as well as the removal of the 262 nm and 268 nm minima, suggest a significant loss in tertiary structure of glycated-HSA.

Thermal denaturation of native and glycated-HSA: Heat induced variations in absorbance at 280 nm were used to investigate the effect of glycation on the thermal stability of HSA. The melting temperatures of native and glycated-HSA were determined to be 63°C and 70°C, respectively. The Tm value increased by 7°C, indicating that glucose modification has stabilised the structure of HSA. (Table/Fig 6) shows the thermal denaturation profiles of native and glycated-HSA.

HPLC study of native and Amadori-HSA: Standard furosine’s HPLC profile (Table/Fig 7)a reveals a well-defined peak with a retention duration of 28.1 minutes. Furosine was not found in native HSA (Table/Fig 7)b, which was used as a control. Whereas, Glycated-HSA displayed a peak with a retention period of 28.3 minutes (Table/Fig 7)c, which corresponds to furosine’s retention duration. It implies that when glucose is incubated with HSA, fructosyl lysine (Amadori adduct) is formed, which is identified as furosine. Furosine, as a result, is a characteristic of early glycation. The furosine peak in NaBH4 decreased glycated-HSA was not visible (Table/Fig 7)d. This indicates that NaBH4 has entirely decreased the Amadori product and that no furosine has formed as a result.

Electrospray Ionisation Mass Spectrometry (ESI-MS) of native and Amadori-HSA: To validate the formation of the Amadori product, hydrolysates of native and glycated-HSA samples were submitted to ESI-MS analysis. The profiles of hydrolysed native and glycated-HSA are shown in (Table/Fig 8) a-b, respectively. The Amadori product (fructosyl lysine) is compatible with the ion at m/z value of 309 (M+H)+, which results from the condensation of lysine residue (Mr 146.16) with glucose (Mr 180) with the loss of a water molecule. The ion with the m/z value of 291 is thought to be the result of a water molecule being lost from the Amadori product. An additional water molecule was lost, resulting in the product ion with m/z of 273. The fragment ion m/z 225 was speculated to form after the removal of a water molecule and the loss of the CHO group from the glucose moiety.

Discussion

Increased protein glycation in hyperglycaemia plays a key role in the pathophysiology of diabetic complications. Many proteins in circulation are modified by Amadori in diabetics (31). Amadori-modified albumin has been found to be an independent and potent trigger of molecular mediators that contribute to diabetes problems, which are alleviated by inhibiting albumin glycation (32),(33). Elevated levels of AGA associate independently with diabetic nephropathy and retinopathy in patients with type 1 diabetes, and positively associate with cardiovascular disease in patients with type 2 diabetes, suggesting that Amadori albumin may serve as a biomarker for diabetic complications.

Reckoning the above detailed facts the present study was performed to characterise Amadori rich glycated HSA. Previously the formation of Amadori-HSA was confirmed by NBT which is a specific and reliable parameter for Amadori products and not for AGEs (34),(35). In the present study, the amount of HMF formed further authenticated the presence of Amadori HSA. Moreover, the extent of Amadori adduct in glycated-HSA samples was also evaluated on boronate affinity matrix. The species retained on the boronate matrix speaks of Amadori product. It may be plausible to think that with increasing concentration of glucose the percentage of the adduct is increased and the formation is also facilitated in a short period of time.

Albumin is a lysine rich protein and it has been shown that specific lysine residues in HSA are involved in non enzymatic glycation in-vivo (36). Early stages of glycation occurs primarily on the e-amino groups of lysine residues, which might play an important role in altering the secondary structure of the protein (17),(37). Amadori products have a definite effect on protein structure since they are persistent ketoamines (38). The far-UV CD results of the present study showed that the incubation of HSA with glucose for 7 days caused an increase in alpha helical content in glycated HSA as compared to native HSA. This is in agreement with an earlier report (39). Furthermore, when glycated HSA was compared to native HSA, the mid-point melting thermal temperature (Tm) was found to be higher in glycated HSA, indicating an increase in alpha helical content, which is consistent with the current study’s Far-UV results.

The most specific and crucial biomarker of early glycation is furosine, which is produced during acid hydrolysis of fructosyl-lysine (25),(40). It is known to be a gold standard of early glycation (41). In the present study, a characteristic peak was obtained in the HPLC profile of glycated HSA similar to the peak found in the HPLC profile of standard furosine suggesting amadori product formation. However, the current study did not repeat the same findings in native HSA.

In a typical non enzymatic glycation reaction, the carbonyl group of reducing sugars (such as glucose) must first react with the free amino groups of a protein to generate Schiff’s base, followed by Amadori rearrangement of the intermediate (42). Previously, LC-MS study was carried out which authenticated the presence of furosine (27). Furthermore, in this study ESI-MS results also substantiated the presence of Amadori products in the glycated HSA. The ESI-MS data is consistent with the above events, and the ions at m/z 309, 273, and 225, respectively, suggest Amadori product, oxonium ion, and furylium ion.

Limitation(s)

Early glycation induces significant structural changes in HSA which might hamper its functional properties. Prospective studies are needed to determine whether increased plasma levels of early glycated albumin in diabetic patients precede the development of diabetic complications. Furthermore, Amadori-glycated albumin inhibition could be a focus for reducing diabetic vascular problems. However, the limitations of the present study were that the in-vitro experimental conditions for glycation of HSA were not exactly the same like in-vivo.

Conclusion

As inferred from the data obtained, authors propose that the alterations induced in albumin by Amadori modification have ramifications for the management of diabetes and its complications. Moreover, evidence has continued to accumulate to the present day that Amadori glycated albumin has clinical relevance and pathophysiologic importance and reducing its formation independent of hyperglycaemia may have therapeutic benefit.

References

1.
Armbruster DA. Fructosamine: Structure, analysis, and clinical usefulness. Clinical Chemistry. 1987;33(12):2153-63. [crossref] [PubMed]
2.
Thornalley P. Clinical significance of glycation. Clin Lab. 1999;45:263-73.
3.
Cohen MP. Intervention strategies to prevent pathogenetic effects of glycated albumin. Arch Biochem Biophys. 2003;419(1):25-30. [crossref] [PubMed]
4.
Chen S, Cohen MP, Lautenslager GT, Shearman CW, Ziyadeh FN. Glycated albumin stimulates TGF-βbgr; 1 production and protein kinase C activity in glomerular endothelial cells. Kidney International. 2001;59(2):673-81. [crossref] [PubMed]
5.
Ziyadeh FN, Han DC, Cohen JA, Guo J, Cohen MP. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: Involvement of the transforming growth factor-β system. Kidney International. 1998;53(3):631-38. [crossref] [PubMed]
6.
Cohen MP. Clinical, pathophysiological and structure/function consequences of modification of albumin by Amadori-glucose adducts. Biochimica et Biophysica Acta (BBA)-General Subjects. 2013;1830(12):5480-85. [crossref] [PubMed]
7.
Monnier VM, Sell DR, Dai Z, Nemet I, Collard F, Zhang J. The role of the amadori product in the complications of diabetes. Annals of the New York Academy of Sciences. 2008;1126(1):81-88. [crossref] [PubMed]
8.
Angulo J, Sa?nchez-Ferrer CF, Peiro? Cn, Mari?n Js, Rodri?guez-Man?as L. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin: Possible mechanisms involved. Hypertension. 1996;28(4):583-92. [crossref] [PubMed]
9.
Amore A, Cirina P, Mitola S, Peruzzi L, Gianoglio B, Rabbone I, et al. Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney International. 1997;51(1):27-35. [crossref] [PubMed]
10.
Mandl-Weber S, Haslinger B, Schalkwijk CG, Sitter T. Early glycated albumin, but not advanced glycated albumin, methylglyoxal, or 3-deoxyglucosone increases the expression of PAI-1 in human peritoneal mesothelial cells. Peritoneal Dialysis International. 2001;21(5):487-94. [crossref] [PubMed]
11.
Hattori Y, Suzuki M, Hattori S, Kasai K. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension. 2002;39(1):22-28. [crossref] [PubMed]
12.
Rodriguez-Manas L, Angulo J, Vallejo S, Peiro C, Sanchez-Ferrer A, Cercas E, et al. Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature. Diabetologia. 2003;46(4):556-66. [crossref] [PubMed]
13.
Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D. Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes. 1982;31(4):283-91. [crossref] [PubMed]
14.
Gillery P, Monboisse J, Maquart F, Borel J. Glycation of proteins as a source of superoxide. Diabete & Metabolisme. 1988;14(1):25-30.
15.
Shaklai N, Garlick RL, Bunn HF. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem. 1984;259(6):3812-17. [crossref]
16.
Rondeau P, Bourdon E. The glycation of albumin: Structural and functional impacts. Biochimie. 2011;93(4):645-58. [crossref] [PubMed]
17.
Barnaby OS, Cerny RL, Clarke W, Hage DS. Comparison of modification sites formed on human serum albumin at various stages of glycation. Clinica Chimica Acta. 2011;412(3-4):277-85. [crossref] [PubMed]
18.
Nakajou K, Watanabe H, Kragh-Hansen U, Maruyama T, Otagiri M. The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochimica et Biophysica Acta (BBA)-General Subjects. 2003;1623(2-3):88-97. [crossref] [PubMed]
19.
Schalkwijk C, Chaturvedi N, Twaafhoven H, Van Hinsbergh V, Stehouwer C. Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients. Eur J Clin Invest. 2002;32(7):500-06. [crossref] [PubMed]
20.
Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, et al. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovascular Diabetology. 2006;5(1):27. [crossref] [PubMed]
21.
Ney KA, Colley KJ, Pizzo SV. The standardization of the thiobarbituric acid assay for nonenzymatic glucosylation of human serum albumin. Analytical Biochemistry. 1981;118(2):294-300. [crossref]
22.
Chesne S, Rondeau P, Armenta S, Bourdon E. Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells. Biochimie. 2006;88(10):1467-77. [crossref] [PubMed]
23.
Andrade MA, Chacón P, Merelo JJ, Morán F. Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network. Protein Eng. 1993;6(4):383-90. [crossref] [PubMed]
24.
Ahmad S, Dixit K, Shahab U, Alam K, Ali A. Genotoxicity and immunogenicity of DNA-advanced glycation end products formed by methylglyoxal and lysine in presence of Cu2+. Biochem Biophys Res Commun. 2011;407(3):568-74. [crossref] [PubMed]
25.
Schleicher E, Wieland O. Specific quantitation by HPLC of protein (lysine) bound glucose in human serum albumin and other glycosylated proteins. J Clin Chem Clin Biochem. 1981;19(2):81-88. [crossref] [PubMed]
26.
Akilliogğlu GH, Çelikbiçak Ö, Salih B, Gökmen V. Monitoring protein glycation by electrospray ionization (ESI) quadrupole time-of-flight (Q-TOF) mass spectrometer. Food Chem. 2017;217:65-73. [crossref] [PubMed]
27.
Arif B, Ashraf JM, Moinuddin, Ahmad J, Arif Z, Alam K. Structural and immunological characterisation of Amadori-rich human serum albumin: Role in diabetes mellitus. Arch Biochem Biophys. 2012;522(1):17-25. [crossref] [PubMed]
28.
Kelly SM, Price NC. The application of circular dichroism to studies of protein folding and unfolding. Biochim Biophys Acta. 1997;1338(2):161-85. [crossref]
29.
Woody RW. Circular dichroism. Methods Enzymol. 1995;246:34-71. [crossref]
30.
Lee JY, Hirose M. Partially folded state of the disulfide-reduced form of human serum albumin as an intermediate for reversible denaturation. J Biol Chem. 1992;267(21):14753-58. [crossref]
31.
Jaleel A, Halvatsiotis P, Williamson B, Juhasz P, Martin S, Nair KS. Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment. Diabetes care. 2005;28(3):645-52. [crossref] [PubMed]
32.
Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, et al. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy. Kidney International. 2005;68(4):1554-61. [crossref] [PubMed]
33.
Cohen MP, Hud E, Wu VY, Shearman CW. Amelioration of diabetes-associated abnormalities in the vitreous fluid by an inhibitor of albumin glycation. Invest Ophthalmol Vis Sci. 2008;49(11):5089-93. [crossref] [PubMed]
34.
Lapolla A, Traldi P, Fedele D. Importance of measuring products of non enzymatic glycation of proteins. Clinical Biochemistry. 2005;38(2):103-15. [crossref] [PubMed]
35.
Johnson RN, Metcalf PA, Baker JR. Fructosamine: A new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clinica Chimica Acta. 1983;127(1):87-95. [crossref]
36.
Watkins NG, Thorpe SR, Baynes JW. Glycation of amino groups in protein. Studies on the specificity of modification of RNase by glucose. J Biol Chem. 1985;260(19):10629-36. [crossref]
37.
Ansari NA, Ali R. Physicochemical analysis of poly-L-lysine: An insight into the changes induced in lysine residues of proteins on modification with glucose. IUBMB life. 2011;63(1):26-29. [crossref] [PubMed]
38.
Baynes J, Watkins N, Fisher C, Hull C, Patrick J, Ahmed M, et al. The Amadori product on protein: Structure and reactions. Prog Clin Biol Res. 1989;304:43-67.
39.
Mohamadi-Nejad A, Moosavi-Movahedi A, Safarian S, Naderi-Manesh M, Ranjbar B, Farzami B, et al. The thermal analysis of nonezymatic glycosylation of human serum albumin: differential scanning calorimetry and circular dichroism studies. Thermochimica Acta. 2002;389(1-2):141-51. [crossref]
40.
Krause R, Knoll K, Henle T. Studies on the formation of furosine and pyridosine during acid hydrolysis of different Amadori products of lysine. European Food Research and Technology. 2003;216(4):277-83. [crossref]
41.
Li Y, Liu X, Meng L, Wang Y. Qualitative and quantitative analysis of furosine in fresh and processed ginsengs. J Ginseng Res. 2018;42(1):21-26. [crossref] [PubMed]
42.
Horvat Å , Jakas A. Peptide and amino acid glycation: New insights into the Maillard reaction. Journal of peptide science: An official publication of the European Peptide Society. 2004;10(3):119-37. [crossref] [PubMed]

DOI and Others

DOI: 10.7860/JCDR/2022/51899.16109

Date of Submission: Aug 13, 2021
Date of Peer Review: Sep 20, 2021
Date of Acceptance: Jan 08, 2022
Date of Publishing: Mar 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? NA
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS: [Jain H et al.]
• Plagiarism X-checker: Aug 17, 2021
• Manual Googling: Jan 06, 2022
• iThenticate Software: Feb 16, 2022 (23%)

Etymology: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com